Showing results (471-480 of 5,804) with videos related to

Sort By:
Pageof 581
Drug Design, Development and Therapy|July 12, 2017
Synthesis and cytotoxic activities of novel 4-methoxy-substituted and 5-methyl-substituted (3'S,4'S)-(-)-cis-khellactone derivatives that induce apoptosis via the intrinsic pathwayJingrun Chen, Junjie Liu, Dongxiao Cui, et al.
Drug Design, Development and Therapy|May 27, 2017
New developments in managing opioid addiction: impact of a subdermal buprenorphine implantMariaLisa Itzoe, Michael Guarnieri
Drug Design, Development and Therapy|July 8, 2017
Enzymatic synthesis and in vitro evaluation of folate-functionalized liposomesBohong Guo, Danqiao Xu, Xiaohong Liu, et al.
Drug Design, Development and Therapy|August 31, 2016
Dexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549)Cody P Coyne, Lakshmi Narayanan
Drug Design, Development and Therapy|August 31, 2016
Novel glyoxalase-I inhibitors possessing a "zinc-binding feature" as potential anticancer agentsQosay A Al-Balas, Mohammad A Hassan, Nizar A Al-Shar'i, et al.
Drug Design, Development and Therapy|January 8, 2010
Conivaptan and its role in the treatment of hyponatremiaJalal K Ghali, Jareer O Farah, Suleiman Daifallah, et al.
Drug Design, Development and Therapy|January 8, 2010
Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agentBrian Casserly, James R Klinger
Drug Design, Development and Therapy|September 8, 2016
Effects of alprostadil and iloprost on renal, lung, and skeletal muscle injury following hindlimb ischemia-reperfusion injury in ratsDilek Erer, Abdullah Özer, Hüseyin Demirtaş, et al.
Drug Design, Development and Therapy|May 8, 2018
A network pharmacology approach to determine the synergetic mechanisms of herb couple for treating rheumatic arthritisXi-Xi Xu, Jian-Ping Bi, Li Ping, et al.
Drug Design, Development and Therapy|May 8, 2018
The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLCYayi He, Sangtian Liu, Jane Mattei, et al.
Pageof 581